Literature DB >> 18471979

Regulation of estrogen receptor alpha by the SET7 lysine methyltransferase.

Krithika Subramanian1, Da Jia, Priya Kapoor-Vazirani, Doris R Powell, Robert E Collins, Dipali Sharma, Junmin Peng, Xiaodong Cheng, Paula M Vertino.   

Abstract

Estrogen receptor alpha (ER) is a ligand-dependent transcription factor. Upon binding estrogen, ER recruits coactivator complexes with histone acetyltransferase or methyltransferase activities to activate downstream target genes. In addition to histones, coactivators can modify ER itself and other proteins in the transactivation complex. Here, we show that ER is directly methylated at lysine 302 (K302) by the SET7 methyltransferase. SET7-mediated methylation stabilizes ER and is necessary for the efficient recruitment of ER to its target genes and for their transactivation. The SET7-ER complex structure reveals the molecular basis for ER peptide recognition and predicts that modifications or mutations of nearby residues would affect K302 methylation. Indeed, a breast cancer-associated mutation at K303 (K303R) alters methylation at K302 in vitro and in vivo. These findings raise the possibility that generation, recognition, and removal of modifications within the ER hinge region generate "ER modification cassettes" that yield distinct patterns for signaling downstream events.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18471979      PMCID: PMC2567917          DOI: 10.1016/j.molcel.2008.03.022

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  54 in total

1.  Direct acetylation of the estrogen receptor alpha hinge region by p300 regulates transactivation and hormone sensitivity.

Authors:  C Wang; M Fu; R H Angeletti; L Siconolfi-Baez; A T Reutens; C Albanese; M P Lisanti; B S Katzenellenbogen; S Kato; T Hopp; S A Fuqua; G N Lopez; P J Kushner; R G Pestell
Journal:  J Biol Chem       Date:  2001-03-09       Impact factor: 5.157

2.  In vitro and in vivo analyses of a Phe/Tyr switch controlling product specificity of histone lysine methyltransferases.

Authors:  Robert E Collins; Makoto Tachibana; Hisashi Tamaru; Kristina M Smith; Da Jia; Xing Zhang; Eric U Selker; Yoichi Shinkai; Xiaodong Cheng
Journal:  J Biol Chem       Date:  2004-12-06       Impact factor: 5.157

3.  TMS1, a novel proapoptotic caspase recruitment domain protein, is a target of methylation-induced gene silencing in human breast cancers.

Authors:  K E Conway; B B McConnell; C E Bowring; C D Donald; S T Warren; P M Vertino
Journal:  Cancer Res       Date:  2000-11-15       Impact factor: 12.701

4.  The human estrogen receptor-alpha is a ubiquitinated protein whose stability is affected differentially by agonists, antagonists, and selective estrogen receptor modulators.

Authors:  A L Wijayaratne; D P McDonnell
Journal:  J Biol Chem       Date:  2001-07-25       Impact factor: 5.157

5.  Synergistic enhancement of nuclear receptor function by p160 coactivators and two coactivators with protein methyltransferase activities.

Authors:  S S Koh; D Chen; Y H Lee; M R Stallcup
Journal:  J Biol Chem       Date:  2001-01-12       Impact factor: 5.157

6.  Regulation of coactivator complex assembly and function by protein arginine methylation and demethylimination.

Authors:  Young-Ho Lee; Scott A Coonrod; W Lee Kraus; Mary Anne Jelinek; Michael R Stallcup
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-24       Impact factor: 11.205

Review 7.  The SRC family of nuclear receptor coactivators.

Authors:  C Leo; J D Chen
Journal:  Gene       Date:  2000-03-07       Impact factor: 3.688

8.  Regulation of chromatin structure by site-specific histone H3 methyltransferases.

Authors:  S Rea; F Eisenhaber; D O'Carroll; B D Strahl; Z W Sun; M Schmid; S Opravil; K Mechtler; C P Ponting; C D Allis; T Jenuwein
Journal:  Nature       Date:  2000-08-10       Impact factor: 49.962

9.  Purification and functional characterization of a histone H3-lysine 4-specific methyltransferase.

Authors:  H Wang; R Cao; L Xia; H Erdjument-Bromage; C Borchers; P Tempst; Y Zhang
Journal:  Mol Cell       Date:  2001-12       Impact factor: 17.970

Review 10.  Cellular and molecular pharmacology of antiestrogen action and resistance.

Authors:  R Clarke; F Leonessa; J N Welch; T C Skaar
Journal:  Pharmacol Rev       Date:  2001-03       Impact factor: 25.468

View more
  138 in total

1.  Ligand binding promotes CDK-dependent phosphorylation of ER-alpha on hinge serine 294 but inhibits ligand-independent phosphorylation of serine 305.

Authors:  Jason M Held; David J Britton; Gary K Scott; Elbert L Lee; Birgit Schilling; Michael A Baldwin; Bradford W Gibson; Christopher C Benz
Journal:  Mol Cancer Res       Date:  2012-06-05       Impact factor: 5.852

2.  Lysine methylation and functional modulation of androgen receptor by Set9 methyltransferase.

Authors:  Soyoung Ko; Jungmi Ahn; Chung S Song; Soyoung Kim; Katarzyna Knapczyk-Stwora; Bandana Chatterjee
Journal:  Mol Endocrinol       Date:  2011-01-27

3.  Lysine methylation of FOXO3 regulates oxidative stress-induced neuronal cell death.

Authors:  Qi Xie; Yumin Hao; Li Tao; Shengyi Peng; Chitong Rao; Hong Chen; Han You; Meng-qiu Dong; Zengqiang Yuan
Journal:  EMBO Rep       Date:  2012-04       Impact factor: 8.807

4.  Tumor suppressor function of RUNX3 in breast cancer.

Authors:  Lin-Feng Chen
Journal:  J Cell Biochem       Date:  2012-05       Impact factor: 4.429

5.  Methylation of the retinoblastoma tumor suppressor by SMYD2.

Authors:  Louis A Saddic; Lisandra E West; Aaron Aslanian; John R Yates; Seth M Rubin; Or Gozani; Julien Sage
Journal:  J Biol Chem       Date:  2010-09-24       Impact factor: 5.157

6.  Negative regulation of NF-kappaB action by Set9-mediated lysine methylation of the RelA subunit.

Authors:  Xiao-Dong Yang; Bo Huang; Mingxi Li; Acacia Lamb; Neil L Kelleher; Lin-Feng Chen
Journal:  EMBO J       Date:  2009-03-05       Impact factor: 11.598

Review 7.  SET for life: biochemical activities and biological functions of SET domain-containing proteins.

Authors:  Hans-Martin Herz; Alexander Garruss; Ali Shilatifard
Journal:  Trends Biochem Sci       Date:  2013-10-20       Impact factor: 13.807

8.  Inhibition of Methyltransferase Setd7 Allows the In Vitro Expansion of Myogenic Stem Cells with Improved Therapeutic Potential.

Authors:  Robert N Judson; Marco Quarta; Menno J Oudhoff; Hesham Soliman; Lin Yi; Chih Kai Chang; Gloria Loi; Ryan Vander Werff; Alissa Cait; Mark Hamer; Justin Blonigan; Patrick Paine; Linda T N Doan; Elena Groppa; WenJun He; Le Su; Regan H Zhang; Peter Xu; Christine Eisner; Marcela Low; Ingrid Barta; Coral-Ann B Lewis; Colby Zaph; Mohammad M Karimi; Thomas A Rando; Fabio M Rossi
Journal:  Cell Stem Cell       Date:  2018-01-25       Impact factor: 24.633

9.  Epigenetic Therapy in Breast Cancer.

Authors:  Maryam B Lustberg; Bhuvaneswari Ramaswamy
Journal:  Curr Breast Cancer Rep       Date:  2011-03

10.  Systematic mapping of posttranslational modifications in human estrogen receptor-alpha with emphasis on novel phosphorylation sites.

Authors:  Christian Atsriku; David J Britton; Jason M Held; Birgit Schilling; Gary K Scott; Bradford W Gibson; Christopher C Benz; Michael A Baldwin
Journal:  Mol Cell Proteomics       Date:  2008-11-03       Impact factor: 5.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.